Real-time enrollment status for this metastatic renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 3:42 AM UTC
| NCT Number | NCT05263050 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Renal Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 111 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fox Chase Cancer Center |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 20, 2026: Clinical trial NCT05263050 is currently recruiting participants. This phase2 study for metastatic renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Fox Chase Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05263050 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05263050 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.